sábado, 4 de mayo de 2024

Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational study

https://www.thelancet.com/action/doSearch?dgcid=hubspot_update_feature_updatealerts_eclinm&text1=COVID-19%20OR%20coronavirus%20OR%20SARS-CoV-2%20OR%202019-nCoV&field1=Title&startPage=&P&utm_campaign=update-eclinm&utm_medium=email&_hsenc=p2ANqtz-9TMy3nkXVsF93EtqK5zYAOgPqMF1HsspD2uTgFDJPfzVr53UFXCcIJXUuIwAhx7sa7AYxN89jVhCYAn5qKuZOCU64Rqg&_hsmi=305204544&utm_content=305165197&utm_source=hs_email

No hay comentarios:

Publicar un comentario